Theragenics Corporation(R) Engages Men In A National Debate On Prostate Cancer

 14.07.2008 07:15   medicalnewstoday.com

Theragenics Corporation, a medical device Company serving the prostate cancer and surgical markets (NYSE: TGX), is challenging men to engage in a national debate surrounding the treatment of the disease that will affect one in six of them - prostate cancer. This week, the Company announced its latest campaign to promote awareness of proven prostate cancer treatment options, "The Great Prostate Debate.

World Urology